These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17535915)

  • 21. The ARF-B23 connection: implications for growth control and cancer treatment.
    Zhang Y
    Cell Cycle; 2004 Mar; 3(3):259-62. PubMed ID: 14726681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype.
    Okuwaki M; Tsujimoto M; Nagata K
    Mol Biol Cell; 2002 Jun; 13(6):2016-30. PubMed ID: 12058066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SMT3IP1, a nucleolar SUMO-specific protease, deconjugates SUMO-2 from nucleolar and cytoplasmic nucleophosmin.
    Nishida T; Yamada Y
    Biochem Biophys Res Commun; 2008 Sep; 374(2):382-7. PubMed ID: 18639523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.
    Yeh CW; Huang SS; Lee RP; Yung BY
    Mol Pharmacol; 2006 Oct; 70(4):1443-53. PubMed ID: 16857742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation.
    Ayrault O; Andrique L; Fauvin D; Eymin B; Gazzeri S; Séité P
    Oncogene; 2006 Dec; 25(58):7577-86. PubMed ID: 16924243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico studies of potential phosphoresidues in the human nucleophosmin/B23: its kinases and related biological processes.
    Ramos-Echazábal G; Chinea G; García-Fernández R; Pons T
    J Cell Biochem; 2012 Jul; 113(7):2364-74. PubMed ID: 22573554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRIM28 Is an E3 Ligase for ARF-Mediated NPM1/B23 SUMOylation That Represses Centrosome Amplification.
    Neo SH; Itahana Y; Alagu J; Kitagawa M; Guo AK; Lee SH; Tang K; Itahana K
    Mol Cell Biol; 2015 Aug; 35(16):2851-63. PubMed ID: 26055329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
    Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
    Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa.
    Nozawa Y; Van Belzen N; Van der Made AC; Dinjens WN; Bosman FT
    J Pathol; 1996 Jan; 178(1):48-52. PubMed ID: 8778315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of nucleophosmin/B23 in the cellular response to curcumin.
    Weng CH; Yung BY; Weng JJ; Wu MH
    J Nutr Biochem; 2011 Jan; 22(1):46-52. PubMed ID: 20303727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
    Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
    Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcription regulation of the rRNA gene by a multifunctional nucleolar protein, B23/nucleophosmin, through its histone chaperone activity.
    Murano K; Okuwaki M; Hisaoka M; Nagata K
    Mol Cell Biol; 2008 May; 28(10):3114-26. PubMed ID: 18332108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB.
    Lin CY; Liang YC; Yung BY
    Cell Signal; 2006 Nov; 18(11):2041-8. PubMed ID: 16725311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of interphase and mitotic phosphorylation on the mobility and location of nucleolar protein B23.
    Negi SS; Olson MO
    J Cell Sci; 2006 Sep; 119(Pt 17):3676-85. PubMed ID: 16912078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell cycle phase-dependent changes of localization and oligomerization states of nucleophosmin / B23.
    Chou YH; Yung BY
    Biochem Biophys Res Commun; 1995 Dec; 217(1):313-25. PubMed ID: 8526928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of the proliferative activity of a cell using new monoclonal antibodies to nucleolar protein B23/nucleophosmin].
    Bulycheva TI; Dergunova NN; Artemenko EG; Dudnik OA; Shpakova AP; Malashenko OS; Zatsepina OV
    Tsitologiia; 2000; 42(10):944-54. PubMed ID: 11200134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein.
    Okuwaki M
    J Biochem; 2008 Apr; 143(4):441-8. PubMed ID: 18024471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ARF suppresses tumor angiogenesis through translational control of VEGFA mRNA.
    Kawagishi H; Nakamura H; Maruyama M; Mizutani S; Sugimoto K; Takagi M; Sugimoto M
    Cancer Res; 2010 Jun; 70(11):4749-58. PubMed ID: 20501856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleophosmin/B23 regulates PCNA promoter through YY1.
    Weng JJ; Yung BY
    Biochem Biophys Res Commun; 2005 Sep; 335(3):826-31. PubMed ID: 16099430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23.
    Liu WH; Yung BY
    Oncogene; 1998 Dec; 17(23):3055-64. PubMed ID: 9881708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.